Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 4,218 | 3,368 | 1,566 | 3,937 | 8,830 |
| Cost of Goods | 2,109 | 1,750 | 617 | 2,074 | 4,702 |
| Gross Profit | 2,109 | 1,618 | 949 | 1,863 | 4,127 |
| Operating Expenses | 4,868 | 4,141 | 4,372 | 2,861 | 4,458 |
| Operating Income | -2,650 | -1,773 | -2,806 | -924 | 371 |
| Interest Expense | 36 | 28 | -2 | 2 | 145 |
| Other Income | 0 | 0 | -4 | 3 | -313 |
| Pre-tax Income | -2,686 | -1,801 | -2,808 | -923 | -87 |
| Income Tax | N/A | N/A | N/A | 3 | 4 |
| Net Income Continuous | -2,686 | -1,801 | -2,790 | -926 | -91 |
| Net Income Discontinuous | -78 | -128 | 651 | -28 | N/A |
| Net Income | $-2,764 | $-1,929 | $-2,139 | $-954 | $-91 |
| EPS Basic Total Ops | -0.07 | -0.05 | -0.06 | -0.03 | 0.00 |
| EPS Basic Continuous Ops | -0.06 | -0.05 | -0.08 | -0.02 | 0.00 |
| EPS Basic Discontinuous Ops | -0.01 | 0.00 | 0.02 | 0.00 | N/A |
| EPS Diluted Total Ops | -0.07 | -0.05 | -0.06 | -0.03 | 0.00 |
| EPS Diluted Continuous Ops | -0.06 | -0.05 | -0.08 | -0.02 | 0.00 |
| EPS Diluted Discontinuous Ops | -0.01 | 0.00 | 0.02 | 0.00 | N/A |
| EBITDA(a) | $-2,449 | $-1,620 | $-2,684 | $-824 | $475 |